Trial Profile
A Randomized, Multi-Center, Double Blind, 3 Arm, Phase I/II Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Disulfiram (Primary) ; Bevacizumab
- Indications Age-related macular degeneration
- Focus Adverse reactions
- Sponsors Ora Bio
- 24 Jun 2014 New trial record